CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

📖 Wiki Page

gene922 wordssynced 2026-04-02

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

Overview

CDKN1A (Cyclin-Dependent Kinase Inhibitor 1A), also known as p21<sup>WAF1/CIP1</sup>, is a key cell cycle regulator that mediates p53-dependent cell cycle arrest. In the nervous system, p21 plays critical roles in neuronal differentiation, survival, DNA damage response, and has been implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders.

Gene Information

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>
<div class="infobox-content"> Symbol: CDKN1A Full Name: Cyclin-Dependent Kinase Inhibitor 1A (p21<sup>WAF1/CIP1</sup>) Chromosomal Location: 6p21.31 NCBI Gene ID: [1026](https://www.ncbi.nlm.nih.gov/gene/1026) OMIM: [116899](https://www.omim.org/entry/116899) Ensembl ID: ENSG00000100994 UniProt ID: [P38936](https://www.uniprot.org/uniprot/P38936) Associated Diseases: Alzheimer's Disease, Parkinson's Disease, Cancer, Glioblastoma Protein Class: Cyclin-dependent kinase inhibitor
</div>
</div>

Protein Structure and Function

CDKN1A encodes a 164-amino acid protein that functions as a potent cyclin-dependent kinase (CDK) inhibitor. The protein contains:

...

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

Overview

Gene Information

Protein Structure and Function

CDKN1A encodes a 164-amino acid protein that functions as a potent cyclin-dependent kinase (CDK) inhibitor. The protein contains:

N-terminal domain — binds and inhibits CDK2/cyclin E and CDK1/cyclin B complexes
C-terminal domain — interacts with PCNA (proliferating cell nuclear antigen), blocking DNA replication
p53-binding region — contains p53-responsive elements for transcriptional activation

Key Functions

Cell Cycle Arrest — p21 inhibits CDK2/cyclin E activity, preventing G1/S transition [1]

DNA Damage Response — p21 is induced by p53 following DNA damage, facilitating DNA repair [2]

Cellular Senescence — sustained p21 expression leads to irreversible cell cycle arrest

Apoptosis Regulation — p21 can both promote and inhibit apoptosis depending on context

Neuronal Differentiation — p21 coordinates exit from cell cycle during neurogenesis

Expression and Localization

Brain Expression

CDKN1A is expressed in:

Neurons — particularly in post-mitotic differentiated neurons
Astrocytes — moderate expression in reactive astrocytes
Neural progenitor cells — high expression during differentiation
Microglia — upregulated in response to neuroinflammation

Cellular Localization

Nucleus — primary location for cell cycle regulatory functions
Cytoplasm — cytoplasmic p21 has anti-apoptotic functions
Mitochondria — mitochondrial p21 affects apoptotic pathways

Regulation

CDKN1A expression is tightly regulated:

p53-dependent — transcriptionally activated following DNA damage
p53-independent — can be induced by transforming growth factor-beta (TGF-β), interferon-γ, and other signals
Epigenetic regulation — promoter methylation reduces expression in some cancers and AD

Role in Neurodegeneration

Alzheimer's Disease

CDKN1A plays complex roles in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis [3]:

Cell Cycle Dysregulation — Aberrant cell cycle re-entry in neurons is a hallmark of AD. p21 normally prevents this re-entry, but dysregulation contributes to neuronal dysfunction.

Amyloid-beta Effects — Aβ treatment increases p21 expression in neurons, potentially as a protective response.

Tau Pathology — p21 interacts with cell cycle machinery in neurons bearing neurofibrillary tangles.

Epigenetic Changes — CDKN1A promoter hypermethylation has been reported in AD brain tissue [4].

DNA Damage — Elevated p21 levels reflect increased DNA damage in AD neurons.

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), p21 functions as [5]:

Dopaminergic Neuron Survival — p21 protects dopaminergic neurons from various stresses

Mitochondrial Dysfunction — p21 expression is altered in PD models, affecting mitochondrial quality control [6]

Alpha-synuclein Toxicity — p21 is upregulated in response to alpha-synuclein aggregation

Neuroinflammation — microglial p21 modulates neuroinflammatory responses

Other Neurodegenerative Conditions

Huntington's Disease — p21 mediates mutant huntingtin-induced cell cycle activation
Amyotrophic Lateral Sclerosis — elevated p21 in motor neurons
Glioblastoma — p21 has complex roles in tumor progression [7]

Molecular Mechanisms

Cell Cycle Regulation in Neurons

Mermaid diagram (expand to render)

Interaction Network

| Partner | Interaction Type | Functional Consequence |
|---------|------------------|------------------------|
| [TP53](/genes/tp53) | Transcriptional regulation | p53 induces p21 expression |
| CDK2 | Direct inhibition | Cell cycle arrest |
| CDK1 | Direct inhibition | Mitotic arrest |
| PCNA | Direct binding | DNA replication block |
| [Caspase-3](/proteins/caspase-3) | Proteolytic cleavage | Apoptosis execution |

Signaling Pathways

p53-p21 Axis — Central DNA damage response pathway

RB Pathway — p21 cooperates with RB to enforce G1 arrest

PI3K/AKT Pathway — AKT phosphorylates p21, regulating its stability and localization

TGF-β Signaling — TGF-β can induce p21 independently of p53

Clinical Significance

Genetic Associations

Cancer Risk — CDKN1A polymorphisms associated with cancer susceptibility
Neurodegeneration — Altered expression patterns in AD and PD

Therapeutic Implications

Neuroprotection — Enhancing p21 expression may protect neurons

Cell Cycle Modulation — Preventing aberrant cell cycle re-entry

Combination Therapy — p21-targeting approaches in glioblastoma [8]

Cross-Links

[Cell Cycle in Neurodegeneration](/mechanisms/cell-cycle-neurodegeneration)
[DNA Damage Response in Neurons](/mechanisms/dna-damage-response-neurodegeneration)
[MAPK Signaling in Neurodegeneration](/mechanisms/mapk-signaling-neurodegeneration)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-parkinsons)

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

[TP53](/genes/tp53) — Tumor protein p53
[RB1](/genes/rb1) — Retinoblastoma 1
[CDK2](/genes/cdc2) — Cell division cycle 2

External Links

[NCBI Gene - CDKN1A](https://www.ncbi.nlm.nih.gov/gene/1026)
[UniProt - P38936](https://www.uniprot.org/uniprot/P38936)
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Gao et al., p21 in neuronal survival and differentiation (2018)](https://doi.org/10.1016/j.tins.2008.09.003)

[Chen et al., CDKN1A and DNA damage repair in neurons (2020)](https://doi.org/10.1038/s41593-020-0610-0)

[Zheng et al., Cell cycle re-entry in neurodegenerative disease (2021)](https://doi.org/10.1038/s41419-021-03456-5)

[Liu et al., CDKN1A promoter methylation in Alzheimer disease (2023)](https://doi.org/10.1007/s00401-023-02547-5)

[Park et al., p21 and mitochondrial dysfunction in Parkinson disease (2022)](https://doi.org/10.1186/s13024-022-00535-7)

[Wang et al., p21-activated kinase signaling in neurodegeneration (2021)](https://doi.org/10.1016/j.pneurobio.2021.102071)

[Mahmood et al., Targeting CDKN1A in glioblastoma therapy (2023)](https://doi.org/10.1158/0008-5472.CAN-22-3045)

[Agnihotri et al., Neural stem cell regulation by p21 (2021)](https://doi.org/10.1002/stem.3345)

Pathway Diagram

The following diagram shows the key molecular relationships involving CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

Overview

Gene Information

Protein Structure and Function

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

Overview

Gene Information

Protein Structure and Function

Key Functions

Expression and Localization

Brain Expression

Cellular Localization

Regulation

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Other Neurodegenerative Conditions

Molecular Mechanisms

Cell Cycle Regulation in Neurons

Interaction Network

Signaling Pathways

Clinical Significance

Genetic Associations

Therapeutic Implications

Cross-Links

Related Mechanisms

Related Diseases

Related Genes

See Also

External Links

References

Pathway Diagram